BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 25, 2015
View Archived Issues
Regeneron designs human antibodies to PD-1
Read More
New MoA: Novel ATAD2 bromodomain inhibitors
Read More
Thomas Jefferson University and University of Pennsylvania present fusion proteins
Read More
FDA grants orphan drug designation to MTG-201 for mesothelioma
Read More
Medivation to acquire all worldwide rights to talazoparib from BioMarin
Read More
IDMC recommends reduction of cardiac toxicity monitoring in PRESENT trial
Read More
FDA accepts IND application for tazemetostat in INI1-negative tumors or synovial sarcoma
Read More
RetroSense Therapeutics' RST-001 obtains FDA clearance to proceed to first-in-human trials
Read More
Jacobus Pharmaceutical reports development of novel antimalarials
Read More
Unsolicited offer to acquire InSite Vision deemed as better than QLT's proposal
Read More
Clinical trial results detailed for tofacitinib in psoriasis
Read More
Daiichi Sankyo announces Japanese approvals for supplementary indications
Read More
Esperance and MD Anderson Cancer Center form EP-100 alliance
Read More
Researchers confirm brain-selectivity of estrogen prodrug, potential for menopause disorders
Read More
FDA awards breakthrough therapy designation to cabozantinib for RCC
Read More
FDA approves Promacta for young children with chronic ITP
Read More
Remicade approved in Japan for entero-Behcet's, neuro-Behcet's and vasculo-Behcet's disease
Read More
Roche acquires nucleic acid purification assets from Lumora
Read More
TxCell receives French government grant to fund Col-Treg development
Read More
Filings accepted for afatinib as second-line treatment for squamous cell carcinoma of the lung
Read More
Pfizer conducting first-in-human study of PF-06751979
Read More
Cristal Therapeutics initiates phase I study of CriPec docetaxel for solid tumors
Read More
Lundbeck announces progress of second quarter 2015 and restructuring
Read More